T. Rowe Price Associates’s HCA Healthcare HCA Stock Holding History

T. Rowe Price Associates’s Portfolio HCA Stock Details HCA Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$523M	Sell	1,366,238 -1,033,134	-43%	-$396M	0.06%	264
2025 Q1	$829M	Buy	2,399,372 +1,091,416	+83%	+$377M	0.1%	191
2024 Q4	$393M	Sell	1,307,956 -97,353	-7%	-$29.2M	0.05%	307
2024 Q3	$571M	Sell	1,405,309 -988,580	-41%	-$402M	0.07%	259
2024 Q2	$769M	Sell	2,393,889 -707,160	-23%	-$227M	0.09%	197
2024 Q1	$1.03B	Sell	3,101,049 -214,416	-6%	-$71.5M	0.13%	162
2023 Q4	$897M	Buy	3,315,465 +188,377	+6%	+$51M	0.12%	166
2023 Q3	$769M	Sell	3,127,088 -2,619,322	-46%	-$644M	0.11%	183
2023 Q2	$1.74B	Sell	5,746,410 -2,227,614	-28%	-$676M	0.24%	77
2023 Q1	$2.1B	Buy	7,974,024 +934,406	+13%	+$246M	0.31%	63
2022 Q4	$1.69B	Buy	7,039,618 +1,734,194	+33%	+$416M	0.27%	82
2022 Q3	$975M	Buy	5,305,424 +354,202	+7%	+$65.1M	0.16%	130
2022 Q2	$832M	Sell	4,951,222 -10,123,663	-67%	-$1.7B	0.11%	203
2022 Q1	$3.78B	Sell	15,074,885 -6,054,049	-29%	-$1.52B	0.38%	45
2021 Q4	$5.43B	Sell	21,128,934 -257,102	-1%	-$66.1M	0.49%	30
2021 Q3	$5.19B	Sell	21,386,036 -566,566	-3%	-$138M	0.49%	33
2021 Q2	$4.54B	Sell	21,952,602 -1,521,734	-6%	-$315M	0.42%	39
2021 Q1	$4.42B	Sell	23,474,336 -1,686,405	-7%	-$318M	0.44%	35
2020 Q4	$4.14B	Buy	25,160,741 +2,231,318	+10%	+$367M	0.42%	43
2020 Q3	$2.86B	Buy	22,929,423 +424,576	+2%	+$52.9M	0.33%	57
2020 Q2	$2.18B	Sell	22,504,847 -221,985	-1%	-$21.5M	0.27%	73
2020 Q1	$2.04B	Buy	22,726,832 +2,605,622	+13%	+$234M	0.32%	62
2019 Q4	$2.97B	Buy	20,121,210 +2,574,337	+15%	+$381M	0.39%	52
2019 Q3	$2.11B	Buy	17,546,873 +1,640,734	+10%	+$198M	0.3%	75
2019 Q2	$2.15B	Buy	15,906,139 +1,375,021	+9%	+$186M	0.3%	75
2019 Q1	$1.89B	Buy	14,531,118 +1,573,152	+12%	+$205M	0.28%	83
2018 Q4	$1.61B	Buy	12,957,966 +2,154,233	+20%	+$268M	0.27%	89
2018 Q3	$1.5B	Buy	10,803,733 +1,403,737	+15%	+$195M	0.22%	108
2018 Q2	$964M	Buy	9,399,996 +1,846,367	+24%	+$189M	0.15%	151
2018 Q1	$733M	Buy	7,553,629 +2,342,060	+45%	+$227M	0.12%	192
2017 Q4	$458M	Sell	5,211,569 -12,685,577	-71%	-$1.11B	0.07%	274
2017 Q3	$1.42B	Sell	17,897,146 -322,952	-2%	-$25.7M	0.24%	98
2017 Q2	$1.59B	Buy	18,220,098 +4,314,218	+31%	+$376M	0.29%	85
2017 Q1	$1.24B	Buy	13,905,880 +5,617,718	+68%	+$500M	0.23%	110
2016 Q4	$613M	Sell	8,288,162 -2,745,850	-25%	-$203M	0.12%	195
2016 Q3	$835M	Sell	11,034,012 -1,155,143	-9%	-$87.4M	0.17%	145
2016 Q2	$939M	Sell	12,189,155 -1,179,921	-9%	-$90.9M	0.2%	128
2016 Q1	$1.04B	Sell	13,369,076 -841,762	-6%	-$65.7M	0.22%	116
2015 Q4	$961M	Buy	14,210,838 +1,908,768	+16%	+$129M	0.2%	126
2015 Q3	$952M	Buy	12,302,070 +388,814	+3%	+$30.1M	0.21%	110
2015 Q2	$1.08B	Buy	11,913,256 +995,014	+9%	+$90.3M	0.22%	113
2015 Q1	$821M	Buy	10,918,242 +273,837	+3%	+$20.6M	0.17%	153
2014 Q4	$781M	Buy	10,644,405 +2,411,206	+29%	+$177M	0.17%	156
2014 Q3	$581M	Buy	8,233,199 +2,709,071	+49%	+$191M	0.13%	191
2014 Q2	$311M	Sell	5,524,128 -794,306	-13%	-$44.8M	0.07%	331
2014 Q1	$332M	Sell	6,318,434 -445,503	-7%	-$23.4M	0.07%	313
2013 Q4	$323M	Sell	6,763,937 -309,610	-4%	-$14.8M	0.07%	309
2013 Q3	$302M	Sell	7,073,547 -296,802	-4%	-$12.7M	0.08%	302
2013 Q2	$266M	Buy	+7,370,349	New	+$266M	0.07%	321